Colorectal Cancer Screening is now translated into multiple languages to help people worldwide understand why, when and how to screen for colorectal cancer
Glucon-D maintained its leadership position with a 59% MAT market share
The collaboration will center on expanding access to Eastman’s Esmeri technology
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
GRIN-NDD is one of the most complex neurodevelopmental disorders with limited treatment options today
KRAS G12C-mutant advanced or metastatic nonsquamous non-small cell lung cancer
The study met its primary endpoint with flying colors
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
Under the terms of the deal, AstraZeneca gains exclusive rights to JAB-23E73 outside of mainland China
Subscribe To Our Newsletter & Stay Updated
